Edgewise Therapeutics, Inc. is a biotechnology company based in the United States that focuses on the development of therapeutic drugs for rare genetic diseases. The company specializes in innovative approaches in gene therapy and targets conditions such as Duchenne muscular dystrophy and other muscle disorders. Edgewise Therapeutics uses advanced scientific methods to develop drugs with the potential to significantly improve the quality of life for patients suffering from these serious and currently challenging-to-treat conditions.